Date: Location: Cost: Dress Code:
Apr 13, 2010 The Charles Hotel
One Bennett Street
Cambridge, MA
800.882.1818
Map It >

$1200 per person

Business Attire

Register
Sponsors
Agenda
Time Agenda
7:15-8:00 am Registration in Main Lobby
7:30 - 8:00 am Networking Breakfast
8:00 am Welcome and Opening Remarks
Christoph Westphal, Sirtris, a GSK Company
8:00-8:15 am Guest Speaker
Bob Coughlin, Massachusetts Biotechnology Council
8:15 - 8:30 am Keynote Speaker
Wyc Grousbeck, Boston Celtics
8:30 - 8:50 am Guest Speaker
Richard Pops, Alkermes
8:50 - 9:35 am VC Panel: Value Creation and Investment Criteria for the New Decade
Panel: Noubar Afeyan, Flagship Ventures; Alex Barkas, Prospect Venture Partners; Ansbert Gadicke, MPM Capital; Kyle Lefkoff, Boulder Ventures; Jeff Leiden, Clarus Ventures; David Mott, New Enterprise Associates
Moderator: J.F. Formela, Atlas Venture
9:35 - 10:00 am Guest Speaker:
Steve Krognes, Genentech
10:00 - 10:15 am Guest Speaker
David Meeker, Genzyme
10:15 - 10:35 am NETWORKING BREAK
10:35 - 10:50 am Guest Speaker
John Maraganore, Alnylam
10:50 - 11:35 am Small Biotech Panel - Transitions: From Big Pharma to Start-up Biotech
Panel: Steve Bernitz, Concert; Bob Gallotto, Alnara; Tom Hughes, Zafgen; Greg Licholai, Proteostasis; Jason Rhodes, Epizyme; Steve Tregay, Forma
Moderator: Adelene Perkins, Infinity
11:35 - 12:05 pm Buyside Panel: Current Themes in BioPharma M&A: Deal Making & Investor Sentiment
Panelists: Denise DeFranco, Finnegan; Stephen DuBois, Camber Capital; Tony Gibney, Leerink Swann; Rajiv Kaul, Fidelity; Adam Koppel, Bain Capital
Moderator: Jim Boylan, Leerink Swann
12:05 - 12:40 pm Lunch Keynote
David Nicholson, SVP, Worldwide Licensing and Knowledge Management, Merck
12:40 - 1:25 pm Panel: Where the Deals Are - What's Hot in 2010?
Michelle Dipp, GSK; Kevin Kuehm, Bayer; Mathai Mammen, Theravance; Mark Miller, Eli Lilly; Tony Rosenberg, Novartis
Moderator: David Donabedian, GSK
1:25 - 2:00 pm Panel: Integration after Acquisition
Bob Bagdorf, Pfizer; Brian McVeigh, GSK; Anna Protopapas, Millennium-Takeda; Barbara Yanni, Merck
Moderator: Barry Greene, Alynlam
2:00 - 2:30 pm Panel: Lessons Learned from Dealmaking
Panel: Richard Douglas, Genzyme; Jean George, ATV Capital; Ed Mathers, New Enterprise Associates; Lauren Silverman, Novartis Option Fund
Moderator: Christian Plaza, Cooley Godward Kronish
2:30 - 2:40 pm Closing Remarks
Christoph Westphal, Sirtris, a GSK Company
2:40 - 4:00 pm One-on-One Networking Session